Erin Wilson
Stock Analyst
(n/a)
# 4,647
Out of 4,655 analysts
19
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Erin Wilson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RPD Rapid7 | Maintains: Equal-Weight | $46 | $39.95 | +15.14% | 4 | Jul 10, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $715 → $732 | $208.58 | +250.94% | 3 | Jul 29, 2021 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $352 → $385 | $180.96 | +112.75% | 1 | Jul 20, 2021 | |
| IQV IQVIA Holdings | Maintains: Outperform | $242 → $265 | $209.16 | +26.70% | 1 | Jul 20, 2021 | |
| MEDP Medpace Holdings | Maintains: Outperform | $200 → $205 | $319.56 | -35.85% | 1 | Jul 20, 2021 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $245 → $250 | $220.40 | +13.43% | 2 | Jul 20, 2021 | |
| ELAN Elanco Animal Health | Upgrades: Outperform | $33 → $38 | $12.60 | +201.59% | 1 | Feb 26, 2021 | |
| FLGT Fulgent Genetics | Downgrades: Underperform | n/a | $21.61 | - | 1 | Jan 8, 2021 | |
| TMO Thermo Fisher | Initiates: Neutral | $341 | $557.92 | -38.88% | 1 | Jan 22, 2020 | |
| INCR InterCure | Maintains: Outperform | $68 → $54 | $1.75 | +2,994.56% | 4 | Nov 14, 2017 |
Rapid7
Jul 10, 2024
Maintains: Equal-Weight
Price Target: $46
Current: $39.95
Upside: +15.14%
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $715 → $732
Current: $208.58
Upside: +250.94%
Charles River Laboratories International
Jul 20, 2021
Maintains: Neutral
Price Target: $352 → $385
Current: $180.96
Upside: +112.75%
IQVIA Holdings
Jul 20, 2021
Maintains: Outperform
Price Target: $242 → $265
Current: $209.16
Upside: +26.70%
Medpace Holdings
Jul 20, 2021
Maintains: Outperform
Price Target: $200 → $205
Current: $319.56
Upside: -35.85%
ICON Public Limited Company
Jul 20, 2021
Maintains: Outperform
Price Target: $245 → $250
Current: $220.40
Upside: +13.43%
Elanco Animal Health
Feb 26, 2021
Upgrades: Outperform
Price Target: $33 → $38
Current: $12.60
Upside: +201.59%
Fulgent Genetics
Jan 8, 2021
Downgrades: Underperform
Price Target: n/a
Current: $21.61
Upside: -
Thermo Fisher
Jan 22, 2020
Initiates: Neutral
Price Target: $341
Current: $557.92
Upside: -38.88%
InterCure
Nov 14, 2017
Maintains: Outperform
Price Target: $68 → $54
Current: $1.75
Upside: +2,994.56%